Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy
Weilin Liu, Hongqi Chen, Zhi Zhu, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1425-1425
Open Access | Times Cited: 20

Showing 20 citing articles:

Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer
Tianqi Shi, Xiaofei Chen, Huihui Ti
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2238-2263
Closed Access | Times Cited: 12
SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis
Fanghui Chen, Liwei Lang, Jianqiang Yang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy
Alice Benoit, Guillaume Vogin, Caroline Duhem, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1787-1787
Open Access | Times Cited: 21
Targeting ferroptosis in melanoma: cancer therapeutics
Khatereh Khorsandi, HomaSadat Esfahani, Saeedeh Keyvani- Ghamsari, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications
Xiaoqian Zhai, Yiyun Lin, Lingling Zhu, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 75, pp. 101-109
Open Access | Times Cited: 16
Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers
Pham Hong Anh Cao, Abishai Dominic, Fabiola Ester Lujan, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 10, pp. 615-637
Closed Access | Times Cited: 5
Molecular and therapeutic landscape of ferroptosis in skin diseases
Jiayuan Le, Yu Meng, Ying Wang, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 15, pp. 1777-1789
Open Access | Times Cited: 5
Ferroptosis enhances the therapeutic potential of oncolytic adenoviruses KD01 against cancer
Wenhuan Li, Teng Ji, J Ye, et al.
Cancer Gene Therapy (2025)
Open Access
Recent advances in oncolytic virus therapy for hepatocellular carcinoma
Licheng Zhu, Yu Lei, Jia Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Radiotherapy-activated NBTXR3 nanoparticles promote ferroptosis through induction of lysosomal membrane permeabilization
Jordan Da Silva, Célia Bienassis, Peter Schmitt, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Therapeutic and prognostic values of ferroptosis signature in glioblastoma
Reza Nedaeinia, Hassan Dianat‐Moghadam, Maedeh Movahednasab, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114597-114597
Closed Access
The role of ferroptosis in virus infections
Jing Wang, Junda Zhu, Shuning Ren, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9
Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer
Junhe Zhang, Yunxi Xiao, Jie Zhang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Regulation of ferroptosis by nanotechnology for enhanced cancer immunotherapy
Haohan Zhou, Yiyun Cheng, Quan Huang, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 921-943
Closed Access | Times Cited: 2
Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma
Linyinxue Dong, Ceeane Paul Dagoc Vargas, Xuechen Tian, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10376-10376
Open Access | Times Cited: 5
Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer
Xiangwen Wang, Liwen Zhou, Hongpeng Wang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 21, pp. 20573-20589
Open Access | Times Cited: 4
Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models
Junjie Ye, Lingjuan Chen, Julia Waltermire, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1021-1021
Open Access | Times Cited: 1
Ferroptosis: mechanism, immunotherapy and role in ovarian cancer
Ke Guo, Miao Lu, Jianlei Bi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Expression Characteristics, Immune Signature, and Prognostic Value of the SOCS Family Identified by Multiomics Integrative Analysis in Liver Cancer
Zhitao Dong, Binghua Dai, Rui Wu, et al.
Cancer Reports (2024) Vol. 7, Iss. 9
Open Access
Progression of oncolytic virus in liver cancer treatment
Xuesi Hua, Siyu Xuan, Yangyang Tang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top